During the past decade, Keio University School of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Keio University School of Medicine" #1 sponsor was "Keio University" with 3 trials, followed by "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored, "Fresenius Kabi Japan" with 1 trials sponsored and "Ministry of Health, Labour and Welfare, Japan" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keio University School of Medicine" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Imperial College London" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "International BFM Study Group" with 1 trials as a collaborator and "Japan Heart Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Keio University School of Medicine" are "Sarcoma" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myelogenous Leukemia" (1 trials), "Chronic Myelogenous Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Keio University School of Medicine" in a lesser frequency.

Most popular intervention types in "Keio University School of Medicine" are "Drug" (7 trials), "Radiation" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "dactinomycin" (2 trials), "vincristine sulfate" (2 trials), "6% hydroxyethyl starch 130/0.4" (1 trials) and "6% hydroxyethyl starch 70/0.5 (Salinhes®)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Keio University School of Medicine" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Keio University School of Medicine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Keio University School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Keio University School of Medicine, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".